Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy

被引:47
|
作者
Kato, Tomoko S. [1 ]
Takayama, Hiroo [2 ]
Yoshizawa, Saeko [3 ]
Marboe, Charles [3 ]
Schulze, P. Christian [1 ]
Farr, Maryjane [1 ]
Naka, Yoshifumi [2 ]
Mancini, Donna [1 ]
Maurer, Mathew S. [1 ]
机构
[1] Columbia Univ, Dept Med, Div Cardiol, Med Ctr, New York, NY 10027 USA
[2] Columbia Univ, Dept Surg, Div Cardiothorac Surg, Med Ctr, New York, NY USA
[3] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA
关键词
MUSCLE CELL DISORGANIZATION; LEFT-VENTRICULAR HYPERTROPHY; HEART-TRANSPLANTATION; CLINICAL-SIGNIFICANCE; ATHLETES HEART; SURVIVAL; PREVALENCE; INFECTION; DIAGNOSIS; FEATURES;
D O I
10.1016/j.amjcard.2012.04.030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac transplantation is a treatment option for patients with hypertrophic cardiomyopathy (HC) who developed refractory heart failure and/or intractable arrhythmia. However, the pretransplant characteristics and post-transplant prognosis for patients with nondilated idiopathic HC has not yet fully elucidated. Therefore, we retrospectively reviewed 813 consecutive transplant recipients undergoing cardiac transplantation at Columbia University Medical Center from 1999 to 2010 and compared the clinical course of 41 patients with idiopathic HC with that of 373 patients with ischemic heart disease and 398 patients with other heart disease. The patients with HC were younger than those with ischemic heart disease (47.8 +/- 14.0 vs 57.1 +/- 9.4 years; p <0.0001). The proportion of patients undergoing ventricular assist devise surgery for bridge-to-transplant was lower in patients with HC than in those with ischemic heart disease or other heart disease (14.6% vs 31.1% vs 35.7%, all p <0.01). The post-transplant survival of those with HC was better than that for those with ischemic heart disease (90.1% vs 85.8% and 83.9% vs 67.1% at 1 and 5 years, respectively; p = 0.0359), although it was not significantly different from those with other heart disease. Proportional hazards analysis revealed that the subjects with HC had reduced post-transplant mortality (hazard ratio 0.4760, 95% confidential interval 0.1889 to 0.9762; p = 0.042) on univariate, but not multivariate, analysis. Most patients with HC had nondilated left ventricles (left ventricular end-diastolic dimension <= 55 mm; n = 27), and post-transplant survival did not differ from that for those with dilated left ventricles (left ventricular end-diastolic dimension >55 mm; n = 14). In conclusion, the post-transplant survival of those with HC did not differ from those of the subjects who underwent transplant for other non-HC indications. (C) 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;110:568-574)
引用
收藏
页码:568 / 574
页数:7
相关论文
共 50 条
  • [1] Survival After Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy
    Maron, Martin S.
    Kalsmith, Benjamin M.
    Udelson, James E.
    Li, Wenjun
    DeNofrio, David
    CIRCULATION-HEART FAILURE, 2010, 3 (05) : 574 - 579
  • [2] Outcomes in Patients With Hypertrophic Cardiomyopathy Awaiting Heart Transplantation
    Cisneros, Julio Zuniga
    Stehlik, Josef
    Selzman, Craig H.
    Drakos, Stavros G.
    McKellar, Stephen H.
    Wever-Pinzon, Omar
    CIRCULATION-HEART FAILURE, 2018, 11 (03) : e004378
  • [3] Hypertrophic Cardiomyopathy in Liver Transplantation Patients
    Pai, S-L
    Aniskevich, S., III
    Logvinov, I. I.
    Matcha, G., V
    Palmer, W. C.
    Blackshear, J. L.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (05) : 1466 - 1469
  • [4] Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI
    Kebed, Kalie Y.
    Al Adham, Raed I.
    Bishu, Kalkidan
    Askew, J. Wells
    Klarich, Kyle W.
    Oh, Jae K.
    Julsrud, Paul R.
    Foley, Thomas A.
    Glockner, James F.
    Nishimura, Rick A.
    Ommen, Steve R.
    Anavekar, Nandan S.
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2014, 30 (03) : 591 - 597
  • [5] Implication of sleep apnea for cardiac remodeling in patients with hypertrophic cardiomyopathy
    Xu, Haobo
    Wang, Wei
    Yuan, Jiansong
    Guo, Chao
    Hu, Fenghuan
    Yang, Weixian
    Luo, Xiaoliang
    Cui, Jingang
    Qiao, Shubin
    Wang, Juan
    SLEEP MEDICINE, 2024, 116 : 115 - 122
  • [6] Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy
    To, Andrew C. Y.
    Dhillon, Ashwat
    Desai, Milind Y.
    JACC-CARDIOVASCULAR IMAGING, 2011, 4 (10) : 1123 - 1137
  • [7] Sex differences in cardiac magnetic resonance features in patients with hypertrophic cardiomyopathy
    Nogales-Romo, Maria Teresa
    Cecconi, Alberto
    Jose Olivera, Maria
    Caballero, Paloma
    Hernandez, Susana
    Jesus Jimenez-Borreguero, Luis
    Alfonso, Fernando
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2020, 36 (09) : 1751 - 1759
  • [8] Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy
    Killu, Ammar M.
    Park, Jae-Yoon
    Sara, Jaskanwal D.
    Hodge, David O.
    Gersh, Bernard J.
    Nishimura, Rick A.
    Asirvatham, Samuel J.
    McLeod, Christopher J.
    EUROPACE, 2018, 20 (01): : 82 - 88
  • [9] Temporal Changes in Cardiac Morphology and Its Relationship with Clinical Characteristics and Outcomes in Patients with Hypertrophic Cardiomyopathy
    Habib, Manhal
    Adler, Arnon
    Hoss, Sara
    Hanneman, Kate
    Katz, Olga
    Habib, Hadeel Halloun
    Fardfini, Kimia
    Rakowski, Harry
    Chan, Raymond H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 176 : 125 - 131
  • [10] The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy
    Finocchiaro, Gherardo
    Sheikh, Nabeel
    Biagini, Elena
    Papadakis, Michael
    Maurizi, Nicolo'
    Sinagra, Gianfranco
    Pelliccia, Antonio
    Rapezzi, Claudio
    Sharma, Sanjay
    Olivotto, Iacopo
    HEART RHYTHM, 2020, 17 (01) : 142 - 151